VANDA PHARMACEUTICALS INC. Number of Operating Segments
VANDA PHARMACEUTICALS INC. (VNDA) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-06
- VANDA PHARMACEUTICALS INC. number of operating segments for the quarter ending 2020-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- VANDA PHARMACEUTICALS INC. number of operating segments for the quarter ending 2019-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- VANDA PHARMACEUTICALS INC. number of operating segments for the quarter ending 2018-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- VANDA PHARMACEUTICALS INC. number of operating segments for the quarter ending 2017-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- VANDA PHARMACEUTICALS INC. number of operating segments for fiscal 2019 was 1.00 Segment, a 0.00% change from fiscal 2018.
- VANDA PHARMACEUTICALS INC. number of operating segments for fiscal 2018 was 1.00 Segment, a 0.00% change from fiscal 2017.
- VANDA PHARMACEUTICALS INC. number of operating segments for fiscal 2017 was 1.00 Segment, a 0.00% change from fiscal 2016.
- VANDA PHARMACEUTICALS INC. number of operating segments for fiscal 2016 was 1.00 Segment.
Segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2020-06-30 | 1.00 Segment 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | 1.00 Segment 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-02-26 | |||
| 2019-09-30 | 1.00 Segment 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | 1.00 Segment 10-Q · filed 2019-08-01 | |||
| 2019-03-31 | 1.00 Segment 10-Q · filed 2019-05-03 | |||
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-02-19 | |||
| 2018-09-30 | 1.00 Segment 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | 1.00 Segment 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | 1.00 Segment 10-Q · filed 2018-05-02 | |||
| 2017-12-31 | 1.00 Segment 10-K · filed 2018-02-15 | |||
| 2017-09-30 | 1.00 Segment 10-Q · filed 2017-11-08 | |||
| 2017-06-30 | 1.00 Segment 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | 1.00 Segment 10-Q · filed 2017-05-03 | |||
| 2016-12-31 | 1.00 Segment 10-K · filed 2017-02-17 | |||
| 2016-09-30 | 1.00 Segment 10-Q · filed 2016-11-03 | |||
| 2016-06-30 | 1.00 Segment 10-Q · filed 2016-07-28 | |||
| 2016-03-31 | 1.00 Segment 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | 1.00 Segment 10-K · filed 2015-03-13 | |||
| 2013-12-31 | 1.00 Segment 10-K · filed 2014-02-25 | |||
| 2012-12-31 | 1.00 Segment 10-K · filed 2013-02-26 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-12 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-07-31 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-14 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-01 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-08 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-07-28 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-03 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-09 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-06 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-24 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-07-29 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-11 | |||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |